SARS-CoV-2 vaccine-induced cerebral venous thrombosis

The nosological entity of the cerebral venous thrombosis caused by the SARS-CoV-2 vaccination differs from the common cerebral venous thrombosis in that it is due to immune thrombocytopenia triggered by vaccination. Cerebral venous thrombosis is one of several manifestations of this type of immune t...

Descripción completa

Detalles Bibliográficos
Autor principal: Ciccone, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:
Clinical Insights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148433/
https://www.ncbi.nlm.nih.gov/pubmed/34090750
http://dx.doi.org/10.1016/j.ejim.2021.05.026
_version_ 1783697836730220544
author Ciccone, Alfonso
author_facet Ciccone, Alfonso
author_sort Ciccone, Alfonso
collection PubMed
description The nosological entity of the cerebral venous thrombosis caused by the SARS-CoV-2 vaccination differs from the common cerebral venous thrombosis in that it is due to immune thrombocytopenia triggered by vaccination. Cerebral venous thrombosis is one of several manifestations of this type of immune thrombocytopenia. Albeit many general aspects of management of cerebral venous thrombosis are similar, immune thrombocytopenia requires a specific therapeutic approach, which is not normally adopted for cerebral venous thrombosis due to other causes, therefore its early recognition is essential.
format Online
Article
Text
id pubmed-8148433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Federation of Internal Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-81484332021-05-26 SARS-CoV-2 vaccine-induced cerebral venous thrombosis Ciccone, Alfonso Eur J Intern Med Clinical Insights The nosological entity of the cerebral venous thrombosis caused by the SARS-CoV-2 vaccination differs from the common cerebral venous thrombosis in that it is due to immune thrombocytopenia triggered by vaccination. Cerebral venous thrombosis is one of several manifestations of this type of immune thrombocytopenia. Albeit many general aspects of management of cerebral venous thrombosis are similar, immune thrombocytopenia requires a specific therapeutic approach, which is not normally adopted for cerebral venous thrombosis due to other causes, therefore its early recognition is essential. European Federation of Internal Medicine. Published by Elsevier B.V. 2021-07 2021-05-25 /pmc/articles/PMC8148433/ /pubmed/34090750 http://dx.doi.org/10.1016/j.ejim.2021.05.026 Text en © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Insights
Ciccone, Alfonso
SARS-CoV-2 vaccine-induced cerebral venous thrombosis
title SARS-CoV-2 vaccine-induced cerebral venous thrombosis
title_full SARS-CoV-2 vaccine-induced cerebral venous thrombosis
title_fullStr SARS-CoV-2 vaccine-induced cerebral venous thrombosis
title_full_unstemmed SARS-CoV-2 vaccine-induced cerebral venous thrombosis
title_short SARS-CoV-2 vaccine-induced cerebral venous thrombosis
title_sort sars-cov-2 vaccine-induced cerebral venous thrombosis
topic Clinical Insights
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148433/
https://www.ncbi.nlm.nih.gov/pubmed/34090750
http://dx.doi.org/10.1016/j.ejim.2021.05.026
work_keys_str_mv AT cicconealfonso sarscov2vaccineinducedcerebralvenousthrombosis

Ejemplares similares